Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Being diagnosed with a rhabdomyosarcoma in the era of artificial intelligence: Whom can we trust?
6
Zitationen
11
Autoren
2024
Jahr
Abstract
In the era of big data, young patients may be overwhelmed by artificial intelligence-based tools, like chatbots. Five clinical experts were asked to evaluate the performance of the most currently used chatbots in providing information on a rare cancer affecting young people, like rhabdomyosarcoma. Generally speaking, despite their high performance in giving general information about the disease, these chatbots were considered by the experts to be inadequate in providing suggestions on cancer treatments and specialized centers, and also lacking in "sensitivity." Efforts are planned by the pediatric oncology community to improve the quality of data used to train these tools.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.578 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.470 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.984 Zit.
BioBERT: a pre-trained biomedical language representation model for biomedical text mining
2019 · 6.814 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.781 Zit.